Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: A prospective observational study
2019
AbstractCirculating tumor cells (CTCs) have received enormous attention as a novel biomarker in various malignant diseases. We investigated the clinical association between the presence of perioperative CTCs and survival outcomes in women with ovarian cancer. In a total of 30 women who were schedule
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
10
Citations
NaN
KQI